Danaher India and THSTI partner to strengthen biomanufacturing capabilities in India
On THSTI’s 16th Foundation Day, Danaher India and THSTI announce collaboration to enhance biomanufacturing skills, infrastructure,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Despite global volatility India’s pharma exports continue to demonstrate steady resilience
Bhavin Mukund Mehta, Whole-Time Director at Kilitch Drugs and Vice-Chairman of Pharmexcil, discusses India’s pharma export…
Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment
HRS9531 achieves significant weight reduction in Phase 3 trial, with plans for NDA submission in China and global development as…
Emcure Pharmaceuticals and Sanofi India sign exclusive distribution agreement for oral anti-diabetic…
Partnership aims to improve access to Amaryl and Cetapin through Emcure’s distribution network, addressing rising diabetes burden…
Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart
KIRSTY will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and…
Agilent launches InfinityLab Pro iQ Series mass detectors in India
The detectors manage workflows, including impurity profiling, biomolecule characterisation, trace-level detection, and mass-based…
Rethinking trust: what pharma can learn from Indian corner shops
Anagha Shirur - Adjunct Faculty, K J Somaiya Institute of Management, expresses how lessons from the kirana shops may offer…
Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare
Framework unveiled in New Delhi by 15 co-authors, corporate and investment CXOs, from Cipla, Zydus, Sun Pharma, Quadria Capital,…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
AATec Medical, Northway Biotech partner to develop industrial production process for ATL-105…
Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital
Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…
Sun Pharma settles with Incyte Corporation in litigation relating to LEQSELVI
The parties will seek dismissal of the pending LEQSELVI litigation in the United States District Court for the District of New…
AstraZeneca gains CDSCO approval for treatment of muscle-invasive bladder cancer
Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData
Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…
Pharmexcil urges balance between compliance and commerce to safeguard India’s export momentum and…
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…
IGI and AbbVie announce exclusive global licensing agreement for ISB 2001
IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…
XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer:…
Pfizer and Astellas Pharma has announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK…
Sai Parenterals secures $5.82M equity investment from Marquee investors
Sai Parenterals has announced the successful completion of a USD 5.82 million (Rs 50 crore) equity investment round by a group of…